Mutual Capital Partners

Mutual Capital Partners, established in 2004, is a private equity firm headquartered in Westlake, Ohio. The company specializes in venture capital investments, focusing on medical device and healthcare IT companies across the United States. It typically leads or co-leads investments, providing not only capital but also strategic guidance and operational support to its portfolio companies. The firm works closely with its network of over 100 investors, leveraging their expertise for due diligence, customer introductions, and ongoing executive counsel.

Liz Todia

Principal

40 past transactions

Catalyst OrthoScience

Venture Round in 2024
Catalyst OrthoScience is an early-stage medical device company focused on developing innovative solutions for orthopedic surgery, specifically with its Catalyst CSR total shoulder system. This system offers a more natural approach to shoulder replacement by minimizing the stretching of muscles and ligaments during implant placement. Unlike traditional shoulder implants that require the removal of the top of the humerus to insert a stem, the Catalyst CSR is designed to be stemless, preserving healthy bone and promoting a less invasive surgical procedure. This design aims to enhance patient recovery by providing a more efficient and streamlined alternative for shoulder replacement surgeries.

Redi.Health

Series B in 2024
Redi.Health is a healthcare technology company based in Columbus, Ohio, founded in 2021. The company specializes in developing health management platforms designed to empower patients, particularly those with chronic diseases, by connecting them to free patient support programs in collaboration with pharmaceutical manufacturers. Its platform enables users to monitor their medication schedules and consolidates health-related information for easy access by healthcare providers. Additionally, Redi.Health offers patients tailored news, tips, and clinical insights, facilitating their ability to navigate healthcare challenges and actively participate in their health journeys.

SPR Therapeutics

Series D in 2024
SPR Therapeutics, LLC is a medical device company focused on developing and commercializing interventional pain management therapies. The company specializes in peripheral nerve stimulation (PNS) products, including its flagship Smartpatch system, which provides short-term pain relief following surgeries and for various types of pain such as neuropathic and musculoskeletal pain. Smartpatch is designed for minimally invasive use, allowing for up to 30 days of electrical stimulation to alleviate pain. Additionally, the company offers the Micropulse system for long-term therapy through an implantable PNS solution. SPR Therapeutics aims to provide a non-narcotic alternative to opioids and invasive procedures, emphasizing safety, effectiveness, and affordability in pain management. Founded in 2009 and headquartered in Cleveland, Ohio, the company also has facilities in the Carolinas and Minneapolis.

iotaMotion

Series A in 2023
iotaMotion, Inc. is a company based in Iowa City, Iowa, that specializes in the development and manufacture of cochlear ear implants aimed at treating hearing loss. Founded in 2015, the company has created a robotic-assisted surgical system designed to standardize the insertion of cochlear implant electrodes. This innovative technology enhances surgical precision by controlling the speed and acceleration of electrode insertion, which helps to reduce variability in surgical procedures. By personalizing the approach to each patient, iotaMotion enables surgeons to provide more accurate and tailored cochlear interventions, ultimately expanding access to these critical treatments for both patients and healthcare providers.

Authenticx

Series B in 2023
Authenticx, Inc. is a software company that specializes in analyzing and activating customer interaction data for the healthcare industry. Founded in 2018 and headquartered in Indianapolis, Indiana, the company offers a platform that consolidates various customer interactions, including data from call centers, texts, chats, and emails, into a unified source of information. This platform enables healthcare organizations to gain insights into customer needs, preferences, and satisfaction levels, facilitating informed decision-making. By organizing and structuring conversational data through a customizable dashboard, Authenticx helps healthcare providers enhance their revenue strategies and improve overall profitability.

Elevation Spine

Series B in 2022
Elevation Spine is a medical device company based in Monterey, California, specializing in the development of innovative spinal implants. The company focuses on creating interbody spinal fusion implants that are designed for minimally invasive procedures. Elevation Spine utilizes proprietary product designs and advanced materials to enhance the effectiveness of its medical devices. Their offerings include an anterior cervical plate and various fixation options that provide a streamlined, single-step integrated fixation solution for spinal surgeries. This design allows medical practitioners to efficiently access pre-loaded spike fixation, thereby improving the overall surgical process.

Redi.Health

Venture Round in 2022
Redi.Health is a healthcare technology company based in Columbus, Ohio, founded in 2021. The company specializes in developing health management platforms designed to empower patients, particularly those with chronic diseases, by connecting them to free patient support programs in collaboration with pharmaceutical manufacturers. Its platform enables users to monitor their medication schedules and consolidates health-related information for easy access by healthcare providers. Additionally, Redi.Health offers patients tailored news, tips, and clinical insights, facilitating their ability to navigate healthcare challenges and actively participate in their health journeys.

Olio

Series A in 2022
Olio Health, Inc. is a technology company that operates a digital platform designed to connect acute and post-acute healthcare providers. Founded in 2017 and based in Carmel, Indiana, Olio's platform enhances communication and provides real-time visibility into patient location and status, facilitating better clinical outcomes. The platform offers features that improve accountability and visibility while streamlining workflows, allowing healthcare providers to manage patients more effectively and engage in value-based care arrangements. By creating a shared language among providers, Olio aims to enhance patient engagement and clinical effectiveness in the healthcare system.

SPR Therapeutics

Series D in 2021
SPR Therapeutics, LLC is a medical device company focused on developing and commercializing interventional pain management therapies. The company specializes in peripheral nerve stimulation (PNS) products, including its flagship Smartpatch system, which provides short-term pain relief following surgeries and for various types of pain such as neuropathic and musculoskeletal pain. Smartpatch is designed for minimally invasive use, allowing for up to 30 days of electrical stimulation to alleviate pain. Additionally, the company offers the Micropulse system for long-term therapy through an implantable PNS solution. SPR Therapeutics aims to provide a non-narcotic alternative to opioids and invasive procedures, emphasizing safety, effectiveness, and affordability in pain management. Founded in 2009 and headquartered in Cleveland, Ohio, the company also has facilities in the Carolinas and Minneapolis.

Catalyst OrthoScience

Series D in 2021
Catalyst OrthoScience is an early-stage medical device company focused on developing innovative solutions for orthopedic surgery, specifically with its Catalyst CSR total shoulder system. This system offers a more natural approach to shoulder replacement by minimizing the stretching of muscles and ligaments during implant placement. Unlike traditional shoulder implants that require the removal of the top of the humerus to insert a stem, the Catalyst CSR is designed to be stemless, preserving healthy bone and promoting a less invasive surgical procedure. This design aims to enhance patient recovery by providing a more efficient and streamlined alternative for shoulder replacement surgeries.

Redi.Health

Seed Round in 2021
Redi.Health is a healthcare technology company based in Columbus, Ohio, founded in 2021. The company specializes in developing health management platforms designed to empower patients, particularly those with chronic diseases, by connecting them to free patient support programs in collaboration with pharmaceutical manufacturers. Its platform enables users to monitor their medication schedules and consolidates health-related information for easy access by healthcare providers. Additionally, Redi.Health offers patients tailored news, tips, and clinical insights, facilitating their ability to navigate healthcare challenges and actively participate in their health journeys.

Checkpoint Surgical

Venture Round in 2021
Checkpoint Surgical Inc., established in 2009 and headquartered in Cleveland, Ohio, specializes in manufacturing neuro devices for surgeons. Their primary products are CHECKPOINT 9094 and CHECKPOINT 9394, both designed to locate, identify, and evaluate motor nerve tissue and muscle function during complex surgical procedures. These devices cater to various applications such as head and neck surgeries, hand and extremities procedures, targeted muscle re-innervation, orthopedic oncology and trauma, and plastic reconstruction. The company sells its products through a network of distributors in the United States, aiming to enhance patient outcomes by providing surgeons with precise nerve stimulation and monitoring equipment.

7SIGNAL

Series D in 2021
7SIGNAL specializes in enterprise wireless experience monitoring, offering a cloud-based platform that continuously tracks the performance of wireless networks. This system is designed to identify performance issues that affect application functionality, focusing on the critical interactions at the edge of Wi-Fi networks where user experience is paramount. By employing an "outside-in" approach, 7SIGNAL provides insights that enhance employee productivity, streamline operations, and improve return on investment for network infrastructure. The platform is utilized by a diverse range of clients, including innovative organizations, educational institutions, healthcare systems, and government agencies, and is currently deployed in Fortune 500 companies and large venues around the world. Additionally, it aids IT enterprises in managing the end-user Wi-Fi experience, reducing the total cost of ownership for wireless LANs by improving troubleshooting efficiency and baseline performance without the need for additional access points.

eBlu Solutions

Series A in 2021
eBlu Solutions LLC specializes in designing and implementing product support programs for pharmaceutical and medical device manufacturers. Established in 2013 and headquartered in Louisville, Kentucky, the company provides services such as benefits investigations, prior authorizations, and co-pay card management. Aimed at assisting specialty medical practices, eBlu Solutions focuses on simplifying the complex workflows associated with high-cost infusion and injection treatments. By offering a single portal for managing these therapies, the company helps practices mitigate financial risk, enhance staff efficiency, and streamline the onboarding process for new employees. Their platform supports real-time eligibility inquiries and monitors patient activity, thereby improving the overall administration of healthcare services. eBlu Solutions operates as a joint venture between KiZan Technologies and Bluegrass Healthcare Management Group.

7SIGNAL

Series D in 2020
7SIGNAL specializes in enterprise wireless experience monitoring, offering a cloud-based platform that continuously tracks the performance of wireless networks. This system is designed to identify performance issues that affect application functionality, focusing on the critical interactions at the edge of Wi-Fi networks where user experience is paramount. By employing an "outside-in" approach, 7SIGNAL provides insights that enhance employee productivity, streamline operations, and improve return on investment for network infrastructure. The platform is utilized by a diverse range of clients, including innovative organizations, educational institutions, healthcare systems, and government agencies, and is currently deployed in Fortune 500 companies and large venues around the world. Additionally, it aids IT enterprises in managing the end-user Wi-Fi experience, reducing the total cost of ownership for wireless LANs by improving troubleshooting efficiency and baseline performance without the need for additional access points.

enosiX

Series A in 2019
enosiX, Inc. specializes in creating integration solutions that connect front-end platforms, particularly Salesforce, with SAP systems. Founded in 2014 and based in Cincinnati, Ohio, the company offers a range of products designed to facilitate seamless data access and business process flows. Their solutions include Enosix Connect for cloud application integration, Enosix Engage for real-time SAP data access without middleware, and various tools for managing sales processes, such as Enosix Sales CPQ, which utilizes SAP data for pricing and quotes. By enabling real-time data sharing, enosiX enhances productivity and customer engagement, allowing sales teams to respond more quickly to opportunities. The company's platform minimizes coding requirements and provides bi-directional integration, ensuring that businesses can leverage SAP data efficiently across various functions, including order management and logistics. Additionally, enosiX supports mobile access to SAP data, empowering a mobile workforce to improve customer relationships and overall productivity.

Catalyst OrthoScience

Series C in 2019
Catalyst OrthoScience is an early-stage medical device company focused on developing innovative solutions for orthopedic surgery, specifically with its Catalyst CSR total shoulder system. This system offers a more natural approach to shoulder replacement by minimizing the stretching of muscles and ligaments during implant placement. Unlike traditional shoulder implants that require the removal of the top of the humerus to insert a stem, the Catalyst CSR is designed to be stemless, preserving healthy bone and promoting a less invasive surgical procedure. This design aims to enhance patient recovery by providing a more efficient and streamlined alternative for shoulder replacement surgeries.

enosiX

Series B in 2018
enosiX, Inc. specializes in creating integration solutions that connect front-end platforms, particularly Salesforce, with SAP systems. Founded in 2014 and based in Cincinnati, Ohio, the company offers a range of products designed to facilitate seamless data access and business process flows. Their solutions include Enosix Connect for cloud application integration, Enosix Engage for real-time SAP data access without middleware, and various tools for managing sales processes, such as Enosix Sales CPQ, which utilizes SAP data for pricing and quotes. By enabling real-time data sharing, enosiX enhances productivity and customer engagement, allowing sales teams to respond more quickly to opportunities. The company's platform minimizes coding requirements and provides bi-directional integration, ensuring that businesses can leverage SAP data efficiently across various functions, including order management and logistics. Additionally, enosiX supports mobile access to SAP data, empowering a mobile workforce to improve customer relationships and overall productivity.

Checkpoint Surgical

Series D in 2018
Checkpoint Surgical Inc., established in 2009 and headquartered in Cleveland, Ohio, specializes in manufacturing neuro devices for surgeons. Their primary products are CHECKPOINT 9094 and CHECKPOINT 9394, both designed to locate, identify, and evaluate motor nerve tissue and muscle function during complex surgical procedures. These devices cater to various applications such as head and neck surgeries, hand and extremities procedures, targeted muscle re-innervation, orthopedic oncology and trauma, and plastic reconstruction. The company sells its products through a network of distributors in the United States, aiming to enhance patient outcomes by providing surgeons with precise nerve stimulation and monitoring equipment.

7SIGNAL

Series C in 2018
7SIGNAL specializes in enterprise wireless experience monitoring, offering a cloud-based platform that continuously tracks the performance of wireless networks. This system is designed to identify performance issues that affect application functionality, focusing on the critical interactions at the edge of Wi-Fi networks where user experience is paramount. By employing an "outside-in" approach, 7SIGNAL provides insights that enhance employee productivity, streamline operations, and improve return on investment for network infrastructure. The platform is utilized by a diverse range of clients, including innovative organizations, educational institutions, healthcare systems, and government agencies, and is currently deployed in Fortune 500 companies and large venues around the world. Additionally, it aids IT enterprises in managing the end-user Wi-Fi experience, reducing the total cost of ownership for wireless LANs by improving troubleshooting efficiency and baseline performance without the need for additional access points.

OrthAlign

Series D in 2017
OrthAlign, Inc. is a medical device company based in Aliso Viejo, California, specializing in surgical navigation products designed for orthopedic procedures, particularly in joint replacement surgeries. The company offers handheld devices such as KneeAlign for total knee arthroplasty, HipAlign for hip surgeries, and UniAlign for unicompartmental knee arthroplasty. These products utilize precise alignment technology in compact, single-use devices that are compatible with various implant systems. OrthAlign's tools provide critical data related to knee stability, angles, and cup placements, aiming to improve surgical outcomes and enhance patient recovery. The company serves orthopedic surgeons, hospitals, and patients through a global network of distributors, with a mission to establish a new standard of care in total joint replacement. Founded in 2004, OrthAlign was previously known as Vitruvian Orthopaedics, Inc. and rebranded in 2009.

7SIGNAL

Series B in 2017
7SIGNAL specializes in enterprise wireless experience monitoring, offering a cloud-based platform that continuously tracks the performance of wireless networks. This system is designed to identify performance issues that affect application functionality, focusing on the critical interactions at the edge of Wi-Fi networks where user experience is paramount. By employing an "outside-in" approach, 7SIGNAL provides insights that enhance employee productivity, streamline operations, and improve return on investment for network infrastructure. The platform is utilized by a diverse range of clients, including innovative organizations, educational institutions, healthcare systems, and government agencies, and is currently deployed in Fortune 500 companies and large venues around the world. Additionally, it aids IT enterprises in managing the end-user Wi-Fi experience, reducing the total cost of ownership for wireless LANs by improving troubleshooting efficiency and baseline performance without the need for additional access points.

Revlocal

Venture Round in 2016
RevLocal, LLC is a digital marketing agency based in Granville, Ohio, specializing in services for local businesses and franchise networks across the United States and Canada. Founded in 1997, the company offers a comprehensive range of digital marketing solutions, including local search engine optimization (SEO), place page optimization, presence management, and mobile website development. Additionally, RevLocal provides review marketing and reputation management services, along with paid advertising options such as search and display ads, retargeting campaigns, and social media advertising. The agency also focuses on social content creation, encompassing social media optimization, blogging, and email marketing. To enhance its offerings, RevLocal employs marketing analytics that include data integration, call tracking, and automatic report generation. By adapting to the evolving digital landscape, RevLocal aims to help businesses improve their online visibility and engage with customers effectively.

Cleveland HeartLab

Venture Round in 2016
Cleveland HeartLab, Inc. is a specialty clinical laboratory dedicated to the prevention and management of cardiovascular disease (CVD). The company specializes in novel biomarker technologies and develops proprietary diagnostic tests aimed at improving the early identification of individuals at risk for CVD. Cleveland HeartLab offers a range of clinical laboratory services, including an inflammatory panel for CVD, advanced CVD risk profiles, and lipid panels. By focusing on innovative molecular biomarker technologies, the company seeks to enhance the management and reduction of inflammation, ultimately contributing to better cardiovascular health outcomes.

7SIGNAL

Series A in 2015
7SIGNAL specializes in enterprise wireless experience monitoring, offering a cloud-based platform that continuously tracks the performance of wireless networks. This system is designed to identify performance issues that affect application functionality, focusing on the critical interactions at the edge of Wi-Fi networks where user experience is paramount. By employing an "outside-in" approach, 7SIGNAL provides insights that enhance employee productivity, streamline operations, and improve return on investment for network infrastructure. The platform is utilized by a diverse range of clients, including innovative organizations, educational institutions, healthcare systems, and government agencies, and is currently deployed in Fortune 500 companies and large venues around the world. Additionally, it aids IT enterprises in managing the end-user Wi-Fi experience, reducing the total cost of ownership for wireless LANs by improving troubleshooting efficiency and baseline performance without the need for additional access points.

Vox Mobile

Series C in 2015
Vox Mobile, Inc. specializes in managed mobility services for enterprises, focusing on mobile technology consulting, management, and support. Founded in 2004 and based in Independence, Ohio, the company assists organizations in developing and executing effective mobile strategies while ensuring the productivity and security of their mobile workforces. Vox Mobile’s offerings include strategic consulting, a mobility management software solution called Vox Choice, and a range of support services such as device imaging, end-user activation, and mobile security. The company also provides audit and optimization services to enhance visibility and manage expenses related to mobile operations. Vox Mobile serves a diverse clientele across various industries, including banking, healthcare, and manufacturing, both in the United States and internationally. As a recognized leader in mobile IT services, Vox Mobile is a founding member of the Global Enterprise Mobility Alliance, enabling it to deliver local account management and global services to its clients.

OrthAlign

Series C in 2014
OrthAlign, Inc. is a medical device company based in Aliso Viejo, California, specializing in surgical navigation products designed for orthopedic procedures, particularly in joint replacement surgeries. The company offers handheld devices such as KneeAlign for total knee arthroplasty, HipAlign for hip surgeries, and UniAlign for unicompartmental knee arthroplasty. These products utilize precise alignment technology in compact, single-use devices that are compatible with various implant systems. OrthAlign's tools provide critical data related to knee stability, angles, and cup placements, aiming to improve surgical outcomes and enhance patient recovery. The company serves orthopedic surgeons, hospitals, and patients through a global network of distributors, with a mission to establish a new standard of care in total joint replacement. Founded in 2004, OrthAlign was previously known as Vitruvian Orthopaedics, Inc. and rebranded in 2009.

enosiX

Series A in 2014
enosiX, Inc. specializes in creating integration solutions that connect front-end platforms, particularly Salesforce, with SAP systems. Founded in 2014 and based in Cincinnati, Ohio, the company offers a range of products designed to facilitate seamless data access and business process flows. Their solutions include Enosix Connect for cloud application integration, Enosix Engage for real-time SAP data access without middleware, and various tools for managing sales processes, such as Enosix Sales CPQ, which utilizes SAP data for pricing and quotes. By enabling real-time data sharing, enosiX enhances productivity and customer engagement, allowing sales teams to respond more quickly to opportunities. The company's platform minimizes coding requirements and provides bi-directional integration, ensuring that businesses can leverage SAP data efficiently across various functions, including order management and logistics. Additionally, enosiX supports mobile access to SAP data, empowering a mobile workforce to improve customer relationships and overall productivity.

7SIGNAL

Series A in 2013
7SIGNAL specializes in enterprise wireless experience monitoring, offering a cloud-based platform that continuously tracks the performance of wireless networks. This system is designed to identify performance issues that affect application functionality, focusing on the critical interactions at the edge of Wi-Fi networks where user experience is paramount. By employing an "outside-in" approach, 7SIGNAL provides insights that enhance employee productivity, streamline operations, and improve return on investment for network infrastructure. The platform is utilized by a diverse range of clients, including innovative organizations, educational institutions, healthcare systems, and government agencies, and is currently deployed in Fortune 500 companies and large venues around the world. Additionally, it aids IT enterprises in managing the end-user Wi-Fi experience, reducing the total cost of ownership for wireless LANs by improving troubleshooting efficiency and baseline performance without the need for additional access points.

Cleveland HeartLab

Series B in 2012
Cleveland HeartLab, Inc. is a specialty clinical laboratory dedicated to the prevention and management of cardiovascular disease (CVD). The company specializes in novel biomarker technologies and develops proprietary diagnostic tests aimed at improving the early identification of individuals at risk for CVD. Cleveland HeartLab offers a range of clinical laboratory services, including an inflammatory panel for CVD, advanced CVD risk profiles, and lipid panels. By focusing on innovative molecular biomarker technologies, the company seeks to enhance the management and reduction of inflammation, ultimately contributing to better cardiovascular health outcomes.

OrthoHelix Surgical Designs

Series D in 2011
OrthoHelix Surgical Designs is a medical device company specializing in the development of implants and instruments for small bone reconstructive surgeries, particularly in the areas of foot, ankle, hand, and wrist. The company offers a range of products, including the DRLock Volar Plate and Screw System, which provides essential fixation solutions for repairing distal radius fractures and performing osteotomies. OrthoHelix aims to enhance surgical outcomes by creating reliable and user-friendly extremity fixation products. The organization prioritizes responsiveness to the needs of surgeons, focusing on delivering tools that facilitate safer and more efficient surgical procedures. Through its commitment to integrity and dedication, OrthoHelix seeks to improve patient outcomes and support healthcare professionals in their work.

OrthoHelix Surgical Designs

Series C in 2010
OrthoHelix Surgical Designs is a medical device company specializing in the development of implants and instruments for small bone reconstructive surgeries, particularly in the areas of foot, ankle, hand, and wrist. The company offers a range of products, including the DRLock Volar Plate and Screw System, which provides essential fixation solutions for repairing distal radius fractures and performing osteotomies. OrthoHelix aims to enhance surgical outcomes by creating reliable and user-friendly extremity fixation products. The organization prioritizes responsiveness to the needs of surgeons, focusing on delivering tools that facilitate safer and more efficient surgical procedures. Through its commitment to integrity and dedication, OrthoHelix seeks to improve patient outcomes and support healthcare professionals in their work.

Hemosphere

Series A in 2010
Hemosphere developed and markets the HeRO (Hemodialysis Reliable Outflow) Graft, a proprietary graft-based solution for end-stage renal disease (ESRD) hemodialysis patients with limited access options and central venous obstruction.

OrthoHelix Surgical Designs

Venture Round in 2009
OrthoHelix Surgical Designs is a medical device company specializing in the development of implants and instruments for small bone reconstructive surgeries, particularly in the areas of foot, ankle, hand, and wrist. The company offers a range of products, including the DRLock Volar Plate and Screw System, which provides essential fixation solutions for repairing distal radius fractures and performing osteotomies. OrthoHelix aims to enhance surgical outcomes by creating reliable and user-friendly extremity fixation products. The organization prioritizes responsiveness to the needs of surgeons, focusing on delivering tools that facilitate safer and more efficient surgical procedures. Through its commitment to integrity and dedication, OrthoHelix seeks to improve patient outcomes and support healthcare professionals in their work.

Mork Process

Series A in 2008
Mork Process for use in the pharmaceutical sector designs and constructs customized clean-in-Place, sterilize-in-Place, and clean-out-of-place systems. These systems are made to provide cleaning cycles, reproducible and predictable cleaning, and reduced use of water and chemicals.

OrthoHelix Surgical Designs

Series B in 2006
OrthoHelix Surgical Designs is a medical device company specializing in the development of implants and instruments for small bone reconstructive surgeries, particularly in the areas of foot, ankle, hand, and wrist. The company offers a range of products, including the DRLock Volar Plate and Screw System, which provides essential fixation solutions for repairing distal radius fractures and performing osteotomies. OrthoHelix aims to enhance surgical outcomes by creating reliable and user-friendly extremity fixation products. The organization prioritizes responsiveness to the needs of surgeons, focusing on delivering tools that facilitate safer and more efficient surgical procedures. Through its commitment to integrity and dedication, OrthoHelix seeks to improve patient outcomes and support healthcare professionals in their work.

OrthoHelix Surgical Designs

Series A in 2006
OrthoHelix Surgical Designs is a medical device company specializing in the development of implants and instruments for small bone reconstructive surgeries, particularly in the areas of foot, ankle, hand, and wrist. The company offers a range of products, including the DRLock Volar Plate and Screw System, which provides essential fixation solutions for repairing distal radius fractures and performing osteotomies. OrthoHelix aims to enhance surgical outcomes by creating reliable and user-friendly extremity fixation products. The organization prioritizes responsiveness to the needs of surgeons, focusing on delivering tools that facilitate safer and more efficient surgical procedures. Through its commitment to integrity and dedication, OrthoHelix seeks to improve patient outcomes and support healthcare professionals in their work.

TGX Medical Systems

Series A in 2005
TGX Medical Systems specializes in the design, development, and marketing of software solutions for medical asset management and tracking. Their web-based systems integrate seamlessly with specialized hardware provided by major integrators, catering to the needs of small, medium, and large hospitals and medical facilities. TGX Medical Systems stands out from its competitors through its sophisticated interfaces, scalability, and ease of modification, which are supported by extensive patents.

CardinalCommerce

Series A in 2004
CardinalCommerce Corporation specializes in payment authentication solutions on a global scale. Founded in 1999 and headquartered in Mentor, Ohio, the company is recognized as a pioneer in authenticating consumer payments online. It operates the largest interoperable authentication network, connecting various card networks, merchants, and financial institutions. CardinalCommerce's product offerings include the One Connection solution for alternative payment options, Authbridge for navigating authentication complexities, and consumer authentication to safeguard transactions while reducing chargebacks. The company also provides digital gift cards, hosted payment pages, mobile banking solutions, and mobile marketing services. Additionally, CardinalCommerce offers tokenization for fraud protection, a universal PIN debit service for secure eCommerce transactions, and a universal wallet for digital wallet and shopping cart compatibility. With strategic partnerships with major payment brands and merchant service providers, CardinalCommerce serves the eCommerce and mCommerce sectors while also delivering advisory services in customer engagement, online security, and fraud prevention. The company maintains facilities in Europe, Africa, North and South America, and distribution centers in Asia and Australia. As of early 2017, it operates as a subsidiary of Visa Inc.

Olio

Olio Health, Inc. is a technology company that operates a digital platform designed to connect acute and post-acute healthcare providers. Founded in 2017 and based in Carmel, Indiana, Olio's platform enhances communication and provides real-time visibility into patient location and status, facilitating better clinical outcomes. The platform offers features that improve accountability and visibility while streamlining workflows, allowing healthcare providers to manage patients more effectively and engage in value-based care arrangements. By creating a shared language among providers, Olio aims to enhance patient engagement and clinical effectiveness in the healthcare system.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.